The availability of multiple disease-modifying medications with regulatory approval to treat
multiple sclerosis illustrates the substantial progress made in therapy of the disease …

A series of 68 patients with neurosarcoidosis is reported, with particular emphasis on clinical
aspects, diagnosis and treatment. A classification system based on clinical diagnostic …

Primary progressive multiple sclerosis (MS) has long been recognised as presenting great
difficulties to our management of what is increasingly a treatable neurological disease. Here …

Although sarcoidosis is rarely confined to the nervous system, any neurological features that
do occur frequently happen early in the course of the disease. The most common …

Idiopathic or primary angiitis of the CNS (PACNS) and cerebral amyloid angiopathy (CAA)
are unusual vasculopathies generally regarded as unrelated disorders. A few case reports …

Methods: The frequency, nature, relationship to systemic features, value of investigation
findings and outcomes for a cohort of patients with neurosarcoidosis (NS) were studied by …

OLIGODENDROCYTES synthesize myelin in the central nervous system and maintain it in
lamellar sheaths around axons. Techniques for studying oligodendrocyte development in …

Background: CNS lupus is a serious but potentially treatable illness, which, though long
recognized, may still present very difficult diagnostic challenges. We believed that further …

Objective: Oligoclonal band (OCB) negative multiple sclerosis (MS) is well recognised but
uncommon, studied in only a few usually small case series. These reached differing …

Interactions between rat microglia and oligodendrocytes were examined in vitro in order to
characterize the stages of adherence, phagocytosis and cytotoxicity against …